Product Information
VELTASSA 8.4 GM POWDER PACKET is a brand product labeled by Vifor Pharma, Inc., priced at $45.4770 per EA under NDC 53436008404. Its NADAC has been published 383 times since Sep 20, 2017.
FDA first approved this application on Oct 21, 2015.
Strength
8.4 g/1
Manufacturer
Vifor Pharma, Inc.NDC
53436008404
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PATIROMERApproval Type
New Drug (NDA)
FDA Application
NDA205739FDA Approved
10/21/2015
On Market Since
10/23/2015
Pharmacological Classes
Price Statistics
The NADAC for VELTASSA 8.4 GM POWDER PACKET has been published 383 times since Sep 20, 2017, and over the history we have for it it has risen 113.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.4770 per EA |
|---|---|
| All-time high | $45.4984 (May 14, 2025) |
| All-time low | $21.2716 (Sep 20, 2017) |
| 52-week high | $45.4770 |
| 52-week low | $45.3898 |
| Median price | $42.3679 |
| Average price | $41.3228 |
| Largest weekly change | +42.2% (Jul 17, 2019) |
| Weeks tracked | 383 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Vifor Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
patiromer market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VELTASSA 8.4 GM POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for VELTASSA 8.4 GM POWDER PACKET, manufactured by Vifor Pharma, Inc., is $45.4770 per EA (NDC 53436008404), effective Sep 30, 2026.
How has the price of VELTASSA 8.4 GM POWDER PACKET changed over time?
Over the history we have for it, the NADAC for VELTASSA 8.4 GM POWDER PACKET has risen 113.8%. It has been tracked across 383 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for VELTASSA 8.4 GM POWDER PACKET?
Since Sep 20, 2017, the NADAC for VELTASSA 8.4 GM POWDER PACKET has ranged from a low of $21.2716 (Sep 20, 2017) to a high of $45.4984 (May 14, 2025), with a median of $42.3679 per EA.
Are there cheaper alternatives to VELTASSA 8.4 GM POWDER PACKET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VELTASSA 8.4 GM POWDER PACKET, is $34.0178 per EA — about 25% below VELTASSA 8.4 GM POWDER PACKET.
Who manufactures VELTASSA 8.4 GM POWDER PACKET?
VELTASSA 8.4 GM POWDER PACKET (NDC 53436008404) is labeled by Vifor Pharma, Inc., and CMS classifies it as a brand product.